FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

9156011000001108: Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1874941000001119 Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1874951000001116 Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml Is a Clarithromycin 125mg/5ml oral suspension 100 ml true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml Is pack of Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml Has active ingredient Clarithromycin false Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml Has AMP Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml Has specific active ingredient Clarithromycin true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start